Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 2
1995 4
1996 8
1997 7
1998 14
1999 16
2000 16
2001 13
2002 10
2003 13
2004 9
2005 8
2006 26
2007 18
2008 22
2009 20
2010 30
2011 13
2012 19
2013 27
2014 11
2015 28
2016 23
2017 23
2018 11
2019 11
2020 5
2021 10
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Results by year

Filters applied: . Clear all
Page 1
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Mehran R, et al. Among authors: serebruany v. Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449. Circulation. 2011. PMID: 21670242 No abstract available.
Conclusion.
Atar D, Serebruany VL. Atar D, et al. Among authors: serebruany vl. Adv Cardiol. 2012;47:165. doi: 10.1159/000341140. Epub 2012 Aug 9. Adv Cardiol. 2012. PMID: 22906911 No abstract available.
Challenging Anticoagulation in Advanced Renal Failure.
Marti HP, Serebruany V, Atar D. Marti HP, et al. Among authors: serebruany v. Am J Med. 2019 Nov;132(11):1258-1259. doi: 10.1016/j.amjmed.2019.07.002. Epub 2019 Jul 26. Am J Med. 2019. PMID: 31356767 No abstract available.
The Reply.
Serebruany VL, Marciniak TA. Serebruany VL, et al. Am J Med. 2017 Aug;130(8):e357-e358. doi: 10.1016/j.amjmed.2017.03.060. Am J Med. 2017. PMID: 28734378 No abstract available.
Should We Use Tegaserod for Irritable Bowel Syndrome?
Marciniak TA, Serebruany V. Marciniak TA, et al. Among authors: serebruany v. Am J Ther. 2019 May/Jun;26(3):e417-e420. doi: 10.1097/MJT.0000000000000947. Am J Ther. 2019. PMID: 30946048
Prasugrel versus clopidogrel.
Serebruany V. Serebruany V. N Engl J Med. 2008 Mar 20;358(12):1298; author reply 1299-301. doi: 10.1056/NEJMc073398. N Engl J Med. 2008. PMID: 18354110 No abstract available.
Vorapaxar and optimal aspirin dose: The FDA outlook.
Serebruany VL, Fortmann SD, Kim MH. Serebruany VL, et al. Int J Cardiol. 2016 Jan 15;203:903-5. doi: 10.1016/j.ijcard.2015.11.064. Epub 2015 Nov 10. Int J Cardiol. 2016. PMID: 26609688 Review.
Prasugrel: the real-life perspective.
Serebruany V, Atar D. Serebruany V, et al. Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):253-4. doi: 10.1161/CIRCOUTCOMES.113.000239. Epub 2013 May 14. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23674315 No abstract available.
392 results